Yourgene Health's (LON: YGEN) share price is trading higher on Tuesday after the company announced the launch of IONA Care.
YGEN's share price is currently priced at 13p, up 1.17% from Monday's close.
IONA Care is a non-invasive prenatal test (NIPT) service offering, measuring the likelihood of a pregnant woman carrying a fetus with aneuploidies and autosomal aneuploidies.
The IONA Care test is carried out on a small maternal blood sample and is performed using the CE-marked IONA Nx NIPT workflow, which utilises next-generation sequencing at the company's Manchester Citylabs 1.0 via Yourgene Genomics Services.
The additional service is aimed at the private clinic testing market in the UK, alongside customers in the Middle East and Turkey.Â
Lyn Rees, CEO of Yourgene Health, commented: “We are thrilled to launch IONA Care, an extension of our IONA advanced prenatal screening service, which builds on the reliability and accuracy of our in-house NIPT service offering, providing pregnant women with more choice.Â
“The enhanced clinical offering is optional, enabling the Company to be more competitive within the NIPT market and we look forward to updating shareholders on our progress.”
Should you invest in Yourgene Health shares?
Yourgene Health shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are Yourgene Health shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies